Eisai
4523.T
$47.70
Share price
0.84%
Change (1 day)
-28.30%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Market capitalization of Eisai (4523.T)
Market cap: NZ$13.45 Billion
As of April 2025 Eisai has a market cap of NZ$13.45 Billion. This makes Eisai the world's 1958th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Eisai from 2000 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$13.45 B | -2.43% |
| 2024 | NZ$13.79 B | -39.19% |
| 2023 | NZ$22.67 B | -22.86% |
| 2022 | NZ$29.40 B | 23.42% |
| 2021 | NZ$23.82 B | -16.1% |
| 2020 | NZ$28.39 B | -11.42% |
| 2019 | NZ$32.05 B | -2.54% |
| 2018 | NZ$32.88 B | 43.63% |
| 2017 | NZ$22.89 B | -3.86% |
| 2016 | NZ$23.81 B | -14.74% |
| 2015 | NZ$27.93 B | 96.18% |
| 2014 | NZ$14.23 B | 5.69% |
| 2013 | NZ$13.47 B | -7.14% |
| 2012 | NZ$14.50 B | -3.11% |
| 2011 | NZ$14.97 B | 12.37% |
| 2010 | NZ$13.32 B | -7.71% |
| 2009 | NZ$14.43 B | -30.78% |
| 2008 | NZ$20.85 B | 36.71% |
| 2007 | NZ$15.25 B | -31.59% |
| 2006 | NZ$22.30 B | 27.15% |
| 2005 | NZ$17.54 B | 32.31% |
| 2004 | NZ$13.25 B | 8% |
| 2003 | NZ$12.27 B | -1.91% |
| 2002 | NZ$12.51 B | -29.2% |
| 2001 | NZ$17.67 B | -24.44% |
| 2000 | NZ$23.39 B |
End of Day market cap according to different sources
On Apr 22nd, 2025 the market cap of Eisai was reported to be:
NZ$13.48 Billion
NZ$13.48 Billion